Check order status

Become part of a community of book lovers from all over the world and get access to a whole bunch of benefits. Create an account for free

DPD courier 4.99 € GLS courier 9.99 €

Contact

How to shop

Help

My account

▸ Empty :-(

Screening for Biological Response Modifiers: Methods and Rationale

Name: Screening for Biological Response Modifiers: Methods and Rationale
Brand: Springer-Verlag New York Inc.
SKU: 02180112
Price: 102.67 EUR
Availability: InStock
Author: James E. Talmadge
ISBN: 9781461296249

James E. Talmadge

Isaiah J. Fidler

R.K. Oldham

Language

English

Book Paperback

Libristo code: 02180112

Publishers Springer-Verlag New York Inc., November 2011

The observation in the 1950s that nitrogen mustard and other toxic chemicals could induce antitumor... Full description

Libristo code: 02180112

249 b

102.67 €

In stock at our supplier Shipping in 5-8 days

Up to 30 days for returns

Customers also purchased

Цирк Самуил Маршак

Hardback

27.73 €

Panenka Cuquita

Toy

48.71 €

Io e Chaser. Tutto quello che ho imparato dal cane più intelligente del mondo John W. Pilley

Hardback

18.04 €

SECRET GARDEN: YOU RAISE ME UP (10TH ANNIVERSARY EDITION) PIANO, VOIX, GUITARE SECRET GARDEN (ARTIS Book

binding.

10.38 €

Zapal mi slunce Christoffer Carlsson

Hardback

17.84 €

Agatha Raisin e l'amore infernale M. C. Beaton

Paperback

13.81 €

Künstlerinnen im Laufe der Geschichte Dandara Cristina Loubak Lima

Paperback

48.81 €

CODA SPURRIER

Hardback

27.73 €

Schadensersatz für Kindesunterhalt. Benedikt Wanke

Paperback

95.21 €

FIESTAS REALES EN LA GRANADA DEL S. XVIII MARTíNEZ RAMOS

Book

30.35 €

Moebius Collection: Die Ferien des Majors / Der Mann von der Ciguri Moebius

Hardback

29.34 €

Ergonoma OLIVERO PULIDO

Book

21.68 €

ABCDaire de Sémiologie à l’ECN Philippe Arlet

Paperback

20.26 €

Zlodějské ticho Petra Nachtmanová

Hardback

7.76 €

Komu věřit, koho oklamat Gerta Vrbová

Paperback

8.16 €

思维智胜高尔夫心术: Outsmarting your brain to play your best golf Tracy Tresidder

Paperback

13.00 €

Die europäischen Staaten nach ihren inneren und äußeren politischen Verhältnissen Ernst von Bülow-Cummerow

Paperback

35.60 €

Le songe de l'astronome Thierry Bourcy

Paperback

11.49 €

Histoire Du Peuple de Dieu, Depuis La Naissance Du Messie. Partie 2, T. 3 Berruyer-I-J

Paperback

29.34 €

Burek na śniadanie Iwicki Argymir

Hardback

12.80 €

Verjährungsfolgen der kaufrechtlichen Nacherfüllung Moritz Menges

Paperback

52.84 €

The observation in the 1950s that nitrogen mustard and other toxic chemicals could induce antitumor responses in patients with refractory lymphoma initiated a massive search for active chemotherapeutic agents. The initial observations stimulated a search for new chemotherapeutic agents which might have increased antitumor activity with less toxicity for normal tissues. To aid in the search for these new chemicals and to attempt to distinguish among the many toxic chemicals which might be candidates for clinical studies, the National Cancer Institute, the pharmaceutical industry, and the cancer research laboratories of most Western nations developed systems for "screening" drugs for antitumor activity. Perhaps the most extensive screening program was established by the National Cancer Institute (1). This screening program has evolved over the last two decades, an evolution which has been repeatedly reviewed (2-5). Various screening programs in use have examined over 500,000 compounds as potential anticancer agents. From these, there are now approximately forty anticancer drugs in clinical use. The utiliy of these compounds and their toxicities have been reviewed on many occasions. It is now apparent that more active and less toxic anticancer drugs are needed. It is also clear that the current screening programs are identifying compounds with similar levels of activity and with continuing moderate to severe toxicity (6).